R$^{2}$Seg: Training-Free OOD Medical Tumor Segmentation via Anatomical Reasoning and Statistical Rejection
Shuaike Shen, Ke Liu, Jiaqing Xie, Shangde Gao, Chunhua Shen, Ge Liu, Mireia Crispin-Ortuzar, Shangqi Gao

TL;DR
R$^{2}$Seg is a training-free, two-stage framework that enhances out-of-distribution tumor segmentation in medical images by combining anatomical reasoning with statistical rejection, significantly reducing false positives.
Contribution
It introduces a novel training-free approach that integrates anatomical reasoning and statistical testing for robust OOD tumor segmentation without parameter updates.
Findings
Significantly improves Dice scores on multi-center benchmarks
Reduces false positives and increases specificity
Compatible with zero-update test-time augmentation
Abstract
Foundation models for medical image segmentation struggle under out-of-distribution (OOD) shifts, often producing fragmented false positives on OOD tumors. We introduce RSeg, a training-free framework for robust OOD tumor segmentation that operates via a two-stage Reason-and-Reject process. First, the Reason step employs an LLM-guided anatomical reasoning planner to localize organ anchors and generate multi-scale ROIs. Second, the Reject step applies two-sample statistical testing to candidates generated by a frozen foundation model (BiomedParse) within these ROIs. This statistical rejection filter retains only candidates significantly different from normal tissue, effectively suppressing false positives. Our framework requires no parameter updates, making it compatible with zero-update test-time augmentation and avoiding catastrophic forgetting. On multi-center and multi-modal…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Neural Network Applications · AI in cancer detection · Generative Adversarial Networks and Image Synthesis
